1. Home
  2. BMR vs AEON Comparison

BMR vs AEON Comparison

Compare BMR & AEON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Beamr Imaging Ltd.

BMR

Beamr Imaging Ltd.

HOLD

Current Price

$1.43

Market Cap

26.9M

Sector

Technology

ML Signal

HOLD

Logo AEON Biopharma Inc.

AEON

AEON Biopharma Inc.

HOLD

Current Price

$0.90

Market Cap

26.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BMR
AEON
Founded
2009
N/A
Country
Israel
United States
Employees
N/A
5
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
26.9M
26.8M
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
BMR
AEON
Price
$1.43
$0.90
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$7.20
AVG Volume (30 Days)
77.1K
74.5K
Earning Date
02-26-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.26
$0.38
52 Week High
$4.32
$1.45

Technical Indicators

Market Signals
Indicator
BMR
AEON
Relative Strength Index (RSI) 39.57 38.01
Support Level N/A $0.87
Resistance Level $1.94 $1.12
Average True Range (ATR) 0.10 0.12
MACD -0.01 -0.02
Stochastic Oscillator 36.89 7.85

Price Performance

Historical Comparison
BMR
AEON

About BMR Beamr Imaging Ltd.

Beamr Imaging Ltd is a video technology and image science software company. It is an innovator of video encoding, transcoding, and optimization solutions that enable high quality, performance, and unmatched bitrate efficiency for video and images. The company is conducted through one operating segment, the optimization technology for video and photo compression. The company operates in Israel, the United States, and the rest of the world, it derives a majority of its revenue from the United States.

About AEON AEON Biopharma Inc.

AEON Biopharma Inc is a clinical stage biopharmaceutical company focused on developing of its proprietary botulinum toxin complex ABP-450 (prabotulinumtoxinA) injection for debilitating medical conditions, with an initial focus on the neurosciences market.

Share on Social Networks: